[Incidence and significance of antibodies to hepatitis delta-antigen in hepatitis B viral infection]. 1987

O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
November 1979, Lancet (London, England),
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
December 1991, The Journal of infectious diseases,
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
January 1981, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
January 1986, Voprosy virusologii,
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
March 1988, Journal of medical virology,
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
January 1987, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
July 1978, Journal of clinical pathology,
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
January 1997, The Turkish journal of pediatrics,
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
January 1986, Voprosy virusologii,
O Jelić, and D Jelić, and I Balen, and I Mihaljević, and M Dominis
January 1982, Journal of medical virology,
Copied contents to your clipboard!